Пациентите с HIV РНК < 400 копия/ ml при режима REYATAZ + ритонавир и лопинавир + ритонавир са съответно 53% и 54%, при ITT анализа.
The proportions of patients with HIV RNA < 400 copies/ ml in the REYATAZ + ritonavir arm and the lopinavir + ritonavir arm were 53% and 54%, respectively, by intent-to-treat analysis, with missing values considered as failures.